| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |